Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
Neo Medical SA’s Series B and $68 Million Equity Investment
Magenta Medical’s $105 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Magenta Medical (Magenta) announced that it has raised $105 million in financing. The financing was...
Novo Holdings’ Acquisition of Majority Stake in Single Use Support
DORDA, Kromann Reumert and Linklaters advised Novo Holdings A/S on the transaction. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on IP Matters. Novo Holdings A/S...
Fractyl Health’s $110 Million Initial Public Offering
Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
Amring Pharmaceuticals’ Acquisition of Visant Medical
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Amring Pharmaceuticals Inc. on the transaction, and Wilson Sonsini Goodrich & Rosati advised Visant Medical. Amring Pharmaceuticals Inc....
Ceribell’s $53 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Ceribell on the deal. Ceribell, innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced the completion of...